Ozempic vs Wegovy
Same Drug, Different Price 2025
Quick Summary
Ozempic and Wegovy contain identical semaglutide but differ in dose and FDA approval. Wegovy (2.4mg, FDA-approved for weight loss) produces 15-17% weight loss vs Ozempic (1mg typical dose, approved for diabetes) at 10-12% loss. Wegovy costs $1,300-1,600/month vs Ozempic $900-1,200/month before insurance. Insurance covers Wegovy for weight loss (45-60% of plans) but rarely covers Ozempic off-label for weight loss without diabetes.
- Same medication (semaglutide), different purposes: Wegovy goes to 2.4mg weekly (weight loss dose), Ozempic maxes at 2mg weekly (diabetes dose)
- Weight loss: Wegovy 15-17% body weight loss; Ozempic off-label 10-12% loss at lower typical doses
- Cost: Wegovy $1,300-1,600/month vs Ozempic $900-1,200/month before insurance—Ozempic cheaper if paying cash
- Insurance: Wegovy covered for weight loss (45-60% of plans with prior auth), Ozempic only covered for diabetes—off-label denied
You’re trying to lose weight. You’ve heard about Ozempic. You’ve heard about Wegovy. You know they work. But you’re confused: Aren’t they the same thing? Why are there two? Which one should you get? Why is one $400 more per month?
Here’s the direct answer: Ozempic and Wegovy are the exact same medication—semaglutide. Wegovy goes up to 2.4mg weekly (optimal weight loss dose, 15-17% weight loss) and is FDA-approved for weight loss. Ozempic maxes at 2mg (typically prescribed at 1mg for diabetes, 10-12% weight loss when used off-label). Wegovy costs more but has better insurance coverage for weight loss. Ozempic costs less out-of-pocket but insurance won’t cover it unless you have diabetes.
This guide tells you exactly which one to get based on your situation, insurance status, and weight loss goals.
The One-Sentence Answer
Same medication (semaglutide), different doses and FDA approvals. Wegovy is designed for weight loss (2.4mg), Ozempic is designed for diabetes (up to 2mg but usually 1mg). Choose based on whether you have insurance, whether you have diabetes, and how much weight you need to lose.
What They Actually Are (Same Drug, Different Branding)
Ozempic: Semaglutide injection FDA-approved for type 2 diabetes. Goes up to 2mg weekly. Prescribed off-label for weight loss at astronomical rates because it works and is (sometimes) cheaper.
Wegovy: Semaglutide injection FDA-approved for chronic weight management. Goes up to 2.4mg weekly. Designed specifically for weight loss.
Same manufacturer (Novo Nordisk), same active ingredient, different marketing and different maximum doses.
The drug works by mimicking GLP-1, a hormone your gut produces after eating. It makes you feel full faster, stay full longer, and reduces cravings. You naturally eat 20-30% fewer calories per day without feeling deprived.
Weight Loss: How Much You’ll Actually Lose
Wegovy 2.4mg (clinical trials, 68 weeks):
- Average: 15-17% body weight loss
- For 220-pound person: 33-37 pounds
- 50% of people lose ≥15% of body weight
- 32% of people lose ≥20% of body weight
Ozempic 1mg (real-world, off-label for weight loss, 68 weeks):
- Average: 10-12% body weight loss
- For 220-pound person: 22-26 pounds
- 30-40% of people lose ≥15% of body weight
Ozempic 2mg (off-label for weight loss, 68 weeks):
- Average: 13-14% body weight loss
- For 220-pound person: 28-31 pounds
- Closer to Wegovy but doesn’t quite reach 2.4mg effectiveness
The pattern: Higher dose = more weight loss. Wegovy’s 2.4mg produces 30-40% more weight loss than Ozempic’s typical 1mg dose.
Cost: The $400/Month Question
Retail prices (before insurance):
- Wegovy: $1,300-1,600/month
- Ozempic: $900-1,200/month
Why Wegovy costs more: Higher maximum dose (2.4mg), single-dose pens, branded specifically for weight loss market.
With insurance:
-
Wegovy: Covered by 45-60% of commercial plans for weight loss (with prior authorization)
- Requirements: BMI ≥27 + weight-related condition OR BMI ≥30
- Usually requires 6-12 months documented diet/exercise attempts
- Typical copay: $25-500/month depending on plan
- Medicare does NOT cover (Part D excludes all weight loss meds)
- Medicaid: Only 15-20 states cover
-
Ozempic: Covered by nearly all insurance for diabetes (with prior auth)
- Requirements: Type 2 diabetes diagnosis (usually A1C ≥7%)
- Off-label use for weight loss (no diabetes) rarely covered
- Insurers are catching off-label weight loss use and denying claims
- Typical copay (for diabetes): $25-200/month
The insurance trap: If you have diabetes, Ozempic is covered and cheaper. If you don’t have diabetes but meet BMI criteria, Wegovy might be covered but Ozempic won’t be.
Which One Should You Actually Get?
Get Wegovy If:
✅ You want maximum weight loss (2.4mg dose produces 15-17% loss) ✅ You have insurance that covers weight loss medications (check first) ✅ You meet FDA weight loss criteria (BMI ≥27 + condition or BMI ≥30) ✅ You don’t have diabetes (Ozempic won’t be covered off-label)
Real scenario: You’re 210 pounds, BMI 32, no diabetes. Your insurance covers Wegovy with prior auth. Copay $100/month. Wegovy is your answer—you’ll lose 30-35 pounds over 12-18 months.
Get Ozempic If:
✅ You have type 2 diabetes (Ozempic is covered, Wegovy might not be) ✅ You’re paying out-of-pocket ($900-1,200/month vs $1,300-1,600/month) ✅ You don’t need maximum dose (1mg may be enough for your goals) ✅ Wegovy is not covered by your insurance but you still want to try semaglutide
Real scenario: You have type 2 diabetes and want to lose weight. Ozempic is covered by insurance ($50 copay/month). You’ll get blood sugar control + 22-26 pounds of weight loss at 1mg dose. Wegovy would cost $1,400/month out-of-pocket for slightly more weight loss. Ozempic is your answer.
Telehealth / Compounded Semaglutide If:
✅ Neither Ozempic nor Wegovy is covered by insurance ✅ You can’t afford $900-1,600/month ✅ You want semaglutide but need budget option
Real scenario: No insurance coverage for either medication. Can’t pay $1,200/month. Use telehealth service offering compounded semaglutide for $200-500/month. Not FDA-approved but same active ingredient, legal, works.
Caveat: Compounded semaglutide quality varies by pharmacy. Less regulatory oversight. But for many people, it’s the only affordable option.
Side Effects: Same for Both
Since both are semaglutide, side effects are identical. Wegovy’s higher 2.4mg dose may cause slightly more nausea/vomiting.
Very common (30-50%):
- Nausea (especially first 8-12 weeks)
- Vomiting
- Diarrhea
- Constipation
- Reduced appetite (this is the point)
Moderate (5-15%):
- Gallstones (rapid weight loss increases risk)
- Acid reflux
- Fatigue
- Injection site reactions
Rare but serious (<1-5%):
- Pancreatitis (severe abdominal pain—stop medication immediately)
- Gastroparesis (stomach paralysis—severe persistent nausea)
- Hypoglycemia (if combined with insulin or other diabetes meds)
Management: Most side effects improve after 8-12 weeks. Eat smaller meals, avoid fatty foods, stay hydrated, use anti-nausea meds if needed. About 5-10% of people stop due to intolerable side effects, usually in first 3 months.
The Dose Escalation (How You Actually Take It)
Both require gradual dose increases to minimize side effects.
Wegovy schedule (designed to reach 2.4mg):
- Month 1: 0.25mg weekly
- Month 2: 0.5mg weekly
- Month 3: 1mg weekly
- Month 4: 1.7mg weekly
- Month 5+: 2.4mg weekly (maintenance)
Ozempic schedule (designed for diabetes control):
- Weeks 1-4: 0.25mg weekly
- Weeks 5+: 0.5mg weekly (many stay here for diabetes)
- Optional: 1mg weekly (most common for weight loss)
- Optional: 2mg weekly (maximum dose)
The difference: Wegovy protocol is designed to get you to 2.4mg. Ozempic protocol stops at whatever dose controls blood sugar (often 0.5mg or 1mg for diabetes, though 1-2mg is used off-label for weight loss).
The Forever Question (What Happens When You Stop)
Both are long-term treatments. You don’t “complete” a course of semaglutide and maintain weight loss. You stay on it or you regain weight.
What happens if you stop:
- 60-70% of people regain weight
- Typically regain two-thirds of lost weight within one year
- Appetite returns to baseline
- Weight plateaus at new higher set point
Why this matters: Factor lifelong medication cost into your decision. $1,200/month × 12 months × 10 years = $144,000 over a decade.
Alternatives: Some people use semaglutide as a “reset,” lose 30-40 pounds, then maintain with diet/exercise. Success rate for this is low (20-30%) but possible.
Your Next Step (Stop Overthinking, Just Pick One)
If you have diabetes and insurance: Ask your doctor for Ozempic. It’s covered. You’ll get blood sugar control + weight loss. Copay $25-200/month.
If you don’t have diabetes but have insurance covering weight loss meds: Ask your doctor for Wegovy. It’s FDA-approved for weight loss. Submit prior auth (requires BMI criteria + documented diet/exercise attempts). Copay $25-500/month.
If you’re paying out-of-pocket: Start with Ozempic 1mg. It costs $300-400/month less than Wegovy and produces 10-12% weight loss. If you need more after 6-12 months, consider switching to Wegovy 2.4mg or increasing Ozempic to 2mg.
If neither is covered and both are too expensive: Use telehealth compounded semaglutide services. $200-500/month. Not FDA-approved but same active ingredient, legal, and it’s your only affordable option.
Most important: Don’t let decision paralysis stop you from starting. Both medications work. The difference between 22 pounds and 33 pounds of weight loss is real but secondary to just starting. Pick the one that’s covered by insurance or that you can afford, and start this week.
This guide provides general information about Ozempic and Wegovy based on clinical evidence. Both medications require prescriptions. Individual results vary. Discuss with healthcare providers about which is appropriate for your situation. Cost and insurance coverage information current as of February 2025 but varies by location and plan.
Key Takeaways
- 1
Wegovy's 2.4mg dose produces 30-40% more weight loss than Ozempic's typical 1mg dose over 68 weeks—dose is the main difference.
- 2
Insurance coverage dramatically better for Wegovy when prescribed for weight loss (BMI ≥27 + condition or ≥30), while Ozempic requires diabetes diagnosis.
- 3
Side effects nearly identical (nausea, vomiting, diarrhea in 30-50%), but Wegovy's higher dose causes slightly more GI symptoms.
- 4
Ozempic more cost-effective out-of-pocket if you don't need maximum 2.4mg dose—can stay at 1mg and save $300-400/month.
- 5
Both are long-term treatments—weight regain occurs in 60-70% who stop, typically regaining two-thirds of lost weight within one year.
- 6
Telehealth services offer both with prescribing flexibility: Wegovy with BMI criteria, Ozempic prescribed off-label for weight loss.
Common Questions About Ozempic vs Wegovy
Common questions about weight-loss answered by our research team.
Q What is the difference between Ozempic and Wegovy?
Ozempic and Wegovy contain identical semaglutide (GLP-1 agonist). Key differences: 1) FDA approval: Wegovy approved for chronic weight management, Ozempic approved only for type 2 diabetes, 2) Maximum dose: Wegovy goes to 2.4mg weekly (optimal weight loss), Ozempic maxes at 2mg weekly (diabetes control), 3) Dosing schedule: Wegovy has 5-month titration reaching 2.4mg, Ozempic titration targets diabetes control usually stopping at 1mg, 4) Cost: Wegovy $1,300-1,600/month vs Ozempic $900-1,200/month before insurance. Same manufacturer (Novo Nordisk), identical semaglutide formulations.
Q Which is better for weight loss, Ozempic or Wegovy?
Wegovy is more effective due to higher 2.4mg dose. Head-to-head data: Wegovy 2.4mg produces 15-17% body weight loss over 68 weeks (33-37 pounds for 220-pound person). Ozempic typical 1mg dose produces 10-12% loss (22-26 pounds for same person). Ozempic maximum 2mg (off-label) produces 13-14% loss, closer to but still below Wegovy. Higher semaglutide dose = greater weight loss, which is why Wegovy's 2.4mg target is optimal. However, Ozempic 1-2mg may be sufficient if you don't need maximum weight loss or experience side effects at higher doses.
Q Does insurance cover Ozempic or Wegovy for weight loss?
Coverage varies dramatically: Wegovy for weight loss (BMI ≥27 + weight-related condition or BMI ≥30): 45-60% of commercial plans cover with prior authorization, typically requiring 6-12 month documented diet/exercise attempts. Medicare does NOT cover any weight loss medications under Part D. Medicaid varies by state—15-20 states cover. Ozempic for weight loss (off-label): Rarely covered unless you have diabetes diagnosis (Type 2 diabetes, A1C ≥7%). Insurers are denying off-label Ozempic for weight loss. Out-of-pocket: Ozempic $900-1,200/month, Wegovy $1,300-1,600/month. Savings programs: Novo Nordisk cards reduce to $25-500/month for eligible patients (exclude government insurance). Compounded semaglutide via telehealth $200-500/month (not FDA-approved).
Q Can I switch from Ozempic to Wegovy or vice versa?
Yes, both contain identical semaglutide, but requires dose conversion. Ozempic to Wegovy: If stable on Ozempic 1mg weekly, provider can switch to Wegovy 1.7mg or 2.4mg weekly to increase weight loss. Most titrate up rather than jumping to 2.4mg. Wegovy to Ozempic: Usually for cost or supply reasons. If on Wegovy 2.4mg, provider switches to Ozempic 2mg (closest dose) or reduces to 1mg if unnecessary. Medications are bioidentical, no washout needed. However, insurance complicates switches—moving from diabetes-approved Ozempic to weight-loss-approved Wegovy requires new prior authorization. Switching Wegovy to Ozempic may raise insurer red flags about off-label use.
Q How much weight can I lose on Ozempic vs Wegovy?
Average weight loss by dose: Wegovy 2.4mg: 15-17% body weight loss over 68 weeks (STEP trials). For 220-pound person, 33-37 pounds. 50% lose ≥15% body weight, 32% lose ≥20%. Ozempic 1mg: 10-12% loss (22-26 pounds for 220-pound person). Ozempic 2mg (off-label): 13-14% loss (28-31 pounds). Results vary: 20-30% are 'super-responders' losing 20%+, while 10-15% are 'non-responders' losing <5%. Success factors: dietary changes adherence (crucial despite reduced appetite), weekly injection consistency, avoiding high-calorie liquids, regular physical activity, adequate time (peak loss at 12-16 months). Weight plateaus after 12-18 months on stable dosing.
Q What are the side effects of Ozempic vs Wegovy?
Nearly identical since both are semaglutide, but Wegovy's higher dose causes slightly more GI symptoms. Common (30-50%): Nausea (most common, especially first 8-12 weeks), vomiting, diarrhea, constipation, abdominal pain, reduced appetite (intended). Moderate (5-15%): Gallstones (risk increases with rapid weight loss), acid reflux, fatigue, injection site reactions. Rare but serious (<1-5%): Pancreatitis (severe abdominal pain), gastroparesis (stomach paralysis causing severe nausea/vomiting), hypoglycemia if combined with insulin/sulfonylureas, thyroid C-cell tumors (theoretical risk from rodent studies, not proven in humans). Most GI side effects improve significantly after 8-12 weeks. Side effect management: titrate slowly, eat smaller meals, avoid fatty foods, stay hydrated, anti-nausea meds if needed. 5-10% discontinue due to intolerable side effects, usually first 3 months.
Q Is it better to get Ozempic or Wegovy through telehealth?
Telehealth offers advantages: Cost transparency: Flat monthly fees ($200-500) for compounded semaglutide, or insurance navigation for brand-name. Accessibility: No in-person visits, useful in areas with limited weight loss specialists. Prescribing flexibility: Telehealth providers prescribe Ozempic off-label for weight loss if you meet BMI criteria but don't have diabetes, or Wegovy if you meet FDA weight loss criteria (BMI ≥27 with comorbidity or ≥30). Supply solutions: During shortages, may offer compounded semaglutide alternatives. Considerations: Compounded semaglutide is NOT FDA-approved (but legal, same active ingredient), quality varies by compounding pharmacy, less clinical oversight than established practices, brand-name costs through telehealth still $900-1,600/month without insurance. Best providers offer comprehensive programs: nutritionist support, medical monitoring, side effect management, not just prescription dispensing.
Have more questions? Our research is continuously updated. If you don't see your question answered here, check our complete guides or contact our team.
Henrik Johansson
MPH - Health Policy Analyst
Medical review by Dr. Amara Okonkwo, PharmD, BCPS - Clinical Pharmacotherapy Specialist
View full profile →